The Oxford University Clinical Research Unit (OUCRU) is a large-scale clinical and public health research unit based in Vietnam. OUCRU aims to have a positive and significant impact on global health and, in particular, the prevention, diagnosis and treatment of infectious diseases. OUCRU enjoys the support of the Vietnamese government, and they work closely with the Ministry of Health Vietnam and the Department of Health of Ho Chi Minh City. OUCRU have developed strong links with more than 20 Vietnamese hospitals and research institutions including HTD, NHTD, The National Institute of Hygiene and Epidemiology (NIHE), and Hanoi Medical University. Priority is given to health issues important to the hospitals, and to Vietnam as a whole. All work is intended not only to benefit the patients seen daily at their host hospitals, but also to help improve patient care throughout Vietnam and the region.
Short film introducing the Wellcome Trust for Human Genetics In the first decades of the 21st century, researchers are beginning to understand in detail how our genetic inheritance makes us who we are. At the Wellcome Trust Centre for Human Genetics, our aim is to extend that understanding in order to gain a clearer insight into mechanisms of health and disease. Looking across all three billion letters of the human genetic code, we aim to pinpoint variant spellings and discover how they increase or decrease an individual’s risk of falling ill. The WTCHG is a research institute of the Nuffield Department of Medicine at the University of Oxford, funded by the University, the Wellcome Trust and numerous other sponsors. It is based in purpose-built laboratories on the University of Oxford’s Biomedical Research Campus in Headington, one of the largest concentrations of biomedical expertise in the world. With more than 400 active researchers and around 70 employed in administrative and support roles, the Centre is an international leader in genetics, genomics and structural biology. We collaborate with research teams across the world on a number of large-scale studies in these areas. Our researchers expend close to £20m annually in competitively-won grants, and publish around 300 primary papers per year.
Meet our Insectary at the Jenner Institute. The Jenner Institute Insectary at the Old Road Campus Research Building is used to test vaccines against malaria, targeting the liver and blood stages of malaria infection. The facility is also used to test transmission-blocking malaria vaccines that aim to halt the sexual development of the malaria parasite in the mosquito.
Meet our Target Discovery Institute. The Target Discovery Institute (TDI) is a new research centre initiated by the Nuffield Department of Medicine and the University of Oxford with a mandate to develop new target screening methodologies, investigate disease pathways as a means for identifying 'drug targets' and advance therapeutically relevant targets for drug development.
Meet the Oxford Branch of the Ludwig Institute for Cancer Research. The Ludwig Institute for Cancer Research Ltd (LICR) is a global non-profit organisation committed to improving the understanding and control of cancer though integrated laboratory and clinical discovery.
Meet the Jenner Institute. The Jenner Institute focuses both on diseases of humans and livestock. One of the founding principles of the Institute is the exploitation of synergies in the development of human and veterinary vaccines whereby new vaccine approaches can be tested in parallel in different species.
Meet our Proteomics facility. We are focussed on using proteomics, mass spectrometry and biochemical approaches to understand the molecular basis of disease processes. The laboratory hosts a platform containing a variety of chromatography equipment and mass spectrometers. We collaborate with many researchers across the University of Oxford campus and elsewhere, applying this technology in the context of biomedical research.